111 related articles for article (PubMed ID: 31506802)
1. The Impact of Beta-Catenin and glutathione-S-transferase Gene Polymorphisms on the Treatment Results and Survival of Multiple Myeloma Patients.
Pál I; Szilágyi B; Nagy B; Pál T; Hodosi K; Illés Á; Váróczy L
Pathol Oncol Res; 2020 Jul; 26(3):1633-1638. PubMed ID: 31506802
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms within beta-catenin encoding gene affect multiple myeloma development and treatment.
Butrym A; Rybka J; Łacina P; Gębura K; Frontkiewicz D; Bogunia-Kubik K; Mazur G
Leuk Res; 2015 Dec; 39(12):1462-6. PubMed ID: 26521987
[TBL] [Abstract][Full Text] [Related]
3. Influence of genetic polymorphisms in CYP3A4, CYP3A5, GSTP1, GSTM1, GSTT1 and MDR1 genes on survival and therapy-related toxicity in multiple myeloma.
Schilthuizen C; Broyl A; van der Holt B; de Knegt Y; Lokhorst H; Sonneveld P
Haematologica; 2007 Feb; 92(2):277-8. PubMed ID: 17296590
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic variation in GSTP1 modulates outcome following therapy for multiple myeloma.
Dasgupta RK; Adamson PJ; Davies FE; Rollinson S; Roddam PL; Ashcroft AJ; Dring AM; Fenton JA; Child JA; Allan JM; Morgan GJ
Blood; 2003 Oct; 102(7):2345-50. PubMed ID: 12791655
[TBL] [Abstract][Full Text] [Related]
5. Functional glutathione S-transferase genotypes among testicular germ cell tumor survivors: associations with primary and post-chemotherapy tumor histology.
Kraggerud SM; Oldenburg J; Alnaes GI; Berg M; Kristensen VN; Fossa SD; Lothe RA
Pharmacogenet Genomics; 2009 Oct; 19(10):751-9. PubMed ID: 19741569
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk.
Maggini V; Buda G; Galimberti S; Martino A; Orciuolo E; Morabito F; Bono R; Barale R; Petrini M; Rossi AM
Leuk Res; 2008 Jun; 32(6):988-90. PubMed ID: 18061666
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-Transferase Gene Polymorphisms and Treatment Outcome in Cervical Cancer Patients under Concomitant Chemoradiation.
Abbas M; Kushwaha VS; Srivastava K; Banerjee M
PLoS One; 2015; 10(11):e0142501. PubMed ID: 26571237
[TBL] [Abstract][Full Text] [Related]
8. An association between glutathione S-transferase P1 gene polymorphism and younger age at onset of lung carcinoma.
Miller DP; Asomaning K; Liu G; Wain JC; Lynch TJ; Neuberg D; Su L; Christiani DC
Cancer; 2006 Oct; 107(7):1570-7. PubMed ID: 16933328
[TBL] [Abstract][Full Text] [Related]
9. Effect of GSTP1 and ABCC2 Polymorphisms on Treatment Response in Patients with Advanced Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy: A Study in a Chinese Uygur Population.
Han ZG; Tao J; Yu TT; Shan L
Med Sci Monit; 2017 Apr; 23():1999-2006. PubMed ID: 28442702
[TBL] [Abstract][Full Text] [Related]
10. Transformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy.
Zhou X; Wang X; Song Q; Yang H; Zhu X; Yu J; Song G; Di L; Ren J; Shao H; Lyerly HK
Int J Clin Pharmacol Ther; 2015 Nov; 53(11):914-22. PubMed ID: 26396136
[TBL] [Abstract][Full Text] [Related]
11. Influence of glutathione S-transferases (GSTM1, GSTT1, and GSTP1) genetic polymorphisms and smoking on susceptibility risk of chronic myeloid leukemia and treatment response.
Rostami G; Assad D; Ghadyani F; Hamid M; Karami A; Jalaeikhoo H; Kalahroodi RA
Mol Genet Genomic Med; 2019 Jul; 7(7):e00717. PubMed ID: 31111691
[TBL] [Abstract][Full Text] [Related]
12. Genetic variation of CTNNB1 gene is associated with susceptibility and prognosis of gastric cancer in a Chinese population.
Wang S; Tian Y; Wu D; Zhu H; Luo D; Gong W; Zhou Y; Zhou J; Zhang Z
Mutagenesis; 2012 Nov; 27(6):623-30. PubMed ID: 22848100
[TBL] [Abstract][Full Text] [Related]
13. Glutathione S-Transferase Pi 1 (GSTP1) Gene 313 A/G (rs1695) polymorphism is associated with the risk of urinary bladder cancer: Evidence from a systematic review and meta-analysis based on 34 case-control studies.
Song Y; Chen J; Liu K; Zhou K; Lu Y; Wang X; Yang Y; Liu X
Gene; 2019 Nov; 719():144077. PubMed ID: 31454540
[TBL] [Abstract][Full Text] [Related]
14. Glutathione S-transferase M1, T1 and P1 polymorphisms: susceptibility and outcome in lung cancer patients.
Sreeja L; Syamala V; Hariharan S; Syamala VS; Raveendran PB; Sivanandan CD; Madhavan J; Ankathil R
J Exp Ther Oncol; 2008; 7(1):73-85. PubMed ID: 18472644
[TBL] [Abstract][Full Text] [Related]
15. Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms.
Maggini V; Buda G; Galimberti S; Conidi E; Giuliani N; Morabito F; Genestreti G; Iacopino P; Rizzoli V; Barale R; Petrini M; Rossi AM
Leuk Res; 2008 Jan; 32(1):49-53. PubMed ID: 17512053
[TBL] [Abstract][Full Text] [Related]
16. Relationship between glutathione S-transferase P1 (GSTP1), X-ray repair cross complementing group 1 (XRCC1) and 5,10-methylenetetrahydrofolate reductase (5,10-MTHFR) gene polymorphisms and response to chemotherapy in advanced gastric cancer.
Ji M; Xu B; Jiang JT; Wu J; Li XD; Zhao WQ; Zhang HY; Zhou WJ; Wu CP
Onkologie; 2013; 36(6):335-40. PubMed ID: 23774147
[TBL] [Abstract][Full Text] [Related]
17. Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia.
Abo-Bakr A; Mossallam G; El Azhary N; Hafez H; Badawy R
J Egypt Natl Canc Inst; 2017 Sep; 29(3):127-133. PubMed ID: 28844589
[TBL] [Abstract][Full Text] [Related]
18. GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy.
Deng X; Yang X; Cheng Y; Liu X; Li X; Zhao R; Qin C; Lu Q; Yin C
Sci Rep; 2015 Sep; 5():14000. PubMed ID: 26354850
[TBL] [Abstract][Full Text] [Related]
19. Glutathione S-transferase P1 mRNA expression in plasma cell disorders and its correlation with polymorphic variants and clinical outcome.
Stella F; Weich N; Panero J; Fantl DB; Schutz N; Fundia AF; Slavutsky I
Cancer Epidemiol; 2013 Oct; 37(5):671-4. PubMed ID: 23953887
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms in genes encoding interleukin-10 and drug metabolizing enzymes GSTP1, GSTT1, GSTA1 and UGT1A1 influence risk and outcome in Hodgkin lymphoma.
Yri OE; Ekstrøm PO; Hilden V; Gaudernack G; Liestøl K; Smeland EB; Holte H
Leuk Lymphoma; 2012 Oct; 53(10):1934-44. PubMed ID: 22475179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
